cysteamine has been researched along with pergolide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cho, SW; Choi, SY; Eum, WS; Han, KH; Hwang, HS; Kang, TC; Kim, DS; Kim, DW; Kim, SM; Kim, YN; Kwon, HY; Lim, SS; Park, J; Sohn, EJ | 1 |
1 review(s) available for cysteamine and pergolide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for cysteamine and pergolide
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Effects of pergolide mesylate on transduction efficiency of PEP-1-catalase protein.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catalase; Cell Line; Cysteamine; Dermatitis; Drug Delivery Systems; Humans; Keratinocytes; Male; Mice; Mice, Inbred ICR; Peptides; Pergolide; Protein Transport; Recombinant Fusion Proteins; Tetradecanoylphorbol Acetate | 2011 |